FINWIRES · TerminalLIVE
FINWIRES

Oncolytics Says Preclinical Results Back Further Evaluation of Pelareorep Plus RAS-Targeted Approaches

By

Oncolytics Biotech (ONCY) said Monday that initial results from a preclinical study assessing pelareorep plus RAS inhibitor modalities in a solid tumor model showed evidence of the combination's greater anti-tumor activity than with the individual approaches alone.

The company said that, based on the results, it is planning further studies in models of pancreatic ductal adenocarcinoma and colorectal cancer to further assess the combinations' anti-tumor and immune effects.

Full results from the initial preclinical studies are slated to be presented in the fall or winter of this year, Oncolytics said.

The company's shares were up more than 8% in Monday premarket trading.

Related Articles

Wire

Susquehanna Adjusts Price Target on MGM Resorts International to $50 From $45, Maintains Positive Rating

MGM Resorts International (MGM) has an average rating of overweight and mean price target of $45.26, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $48.57, Change: $+4.90, Percent Change: +11.22%

$MGM
Wire

JPMorgan Adjusts Price Target on VeriSign to $285 From $278, Maintains Neutral Rating

VeriSign (VRSN) has an average rating of hold and mean price target of $308.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $288.87, Change: $+3.49, Percent Change: +1.22%

$VRSN
Wire

Janus Living Launches Offering of 25 Million Shares

Janus Living (JAN) said Monday it launched a public offering of 25 million shares of class A-1 common stock.Underwriters are expected to be granted a 30-day option to purchase up to about 3.8 million additional shares.The senior housing-focused REIT said it plans to use the net proceeds to pursue acquisition and investment opportunities that meet its criteria, as well as for general corporate purposes.Shares of the company fell more than 4% in recent premarket activity Monday.Price: $25.54, Change: $-1.23, Percent Change: -4.59%

$JAN